Bicara Therapeutics announces Nasdaq Rule 5635(c)(4) inducement grant
Bicara Therapeutics (BCAX) announces an inducement grant under Nasdaq Listing Rule 5635(c)(4), as stated in the provided release text.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.